FDA Announces Approval of Guidance for Blood Manufacturing Practices

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a guidance document on current good manufacturing practice for blood and blood components, specifically addressing the handling of blood units from donors with repeatedly reactive anti-HCV tests.